Clinical profile of patients hospitalized with hemoptysis

Abstract

A BSTRACT Introduction: Hemoptysis presents as a primary complaint in 8–15% of chest clinic patients. The etiology of hemoptysis varies among different series according to the time of publication, geographic location, and diagnostic tests employed. Aim: To study the clinical profile of patients hospitalized with hemoptysis at a tertiary respiratory care center in New Delhi, India. Methods: The study was a cross-sectional, observational, hospital-based study. Patients admitted with hemoptysis in emergency from November 2017 to April 2018 were enrolled. A total of 129 patients were evaluated by a detailed clinical history and necessary investigations deemed required for arriving at the diagnosis. Subjects’ hospitalized details were recorded using structured evaluation proforma. Data were evaluated using SPSS version 22.0. The ‘p’ value of less than 0.05 was considered statistically significant. Results: A total of 129 patients were recruited, with a mean age of 42.67 years, 59.7% were male. Mild, moderate, severe, and massive hemoptysis were seen in 15.5%, 46.5%, 25.6% and 12.4% cases, respectively. History of pulmonary tuberculosis treatment was present in 40.3%, recurrent hemoptysis in 38% and bilateral chest x-ray involvement in 62.6% cases. Tuberculosis (active and sequelae) was the most common cause (51.9%) of hemoptysis. Recurrent hemoptysis and low hemoglobin were found to be independent risk factors associated with the severity of hemoptysis. Conclusion: Tuberculosis remains a significant cause of hemoptysis in our country. Even one episode of hemoptysis should not be ignored and investigated properly as it can potentially cause massive hemoptysis and life-threatening complications in the future.

A Comparison of Clinical and Radiographic Signs of Nontuberculous Mycobacterial Pulmonary Disease, Destructive Drug-Resistant Pulmonary Tuberculosis and a Combination of Nontuberculous Mycobacterium Pulmonary Disease and Pulmonary Tuberculosis

“…However, symptoms such as hemoptysis occurred much more frequently in Group 1 and Group 2 in comparison with Group 3. It is well known that hemoptysis is common among patients with pTB [ 41 , 42 , 43 , 44 , 45 ]. On the other hand, there are not too many trials that investigate hemoptysis among patients with NTMPD [ 46 , 47 ], and we do not find any among patients with a combination of NTMPD and pTB.…”

Influence of non-tuberculous bacterial infection on prognosis of hemoptysis

“…The formation and clearance of brin in high-coagulation vessels caused by infection is imbalanced [19]. Secondary bacterial infection has higher morbidity and mortality [20], which mainly triggers PLT-driven systemic in ammation-related immunosuppression. Weak immune and severe complications in elderly patients are easy to lead to severe secondary bacterial infection.…”